Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry labeled v3.6.3, indicating the record has been updated to a newer saved version.
    Difference
    0.1%
    Check dated 2026-07-03T23:55:14.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision history now shows a new entry for v3.6.2 and removes the v3.6.0 entry, updating the page's version log. This reflects internal version control for the page and does not alter the study data or status.
    Difference
    0.1%
    Check dated 2026-06-26T22:57:40.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page now shows that recruitment is no longer open to participants, clarifying that enrollment has ended. The record history reflects a new revision (v3.6.0) replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T14:11:32.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.5) was added to the study record history, replacing the previous revision (v3.5.4), reflecting an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-06-05T09:54:31.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new history entry (version 9) with a Study Status update was added for 2026-05-19, expanding the record’s current-state information. The entry dated 2025-12-23 was removed from the history.
    Difference
    0.4%
    Check dated 2026-05-22T07:49:44.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The record history now shows a new Revision: v3.5.4, replacing the prior Revision: v3.5.3. This represents a metadata update to the study record's history rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-05-14T23:07:32.000Z thumbnail image

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.